Ascites Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Ascites Epidemiology Forecast Report Coverage

Expert Market Research's “Ascites Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of ascites. It projects the future incidence and prevalence rates of ascites cases across various populations. The study covers age, gender, and type as major determinants of the ascites population. The report highlights patterns in the prevalence of ascites over time and projects future trends based on multiple variables.

Ascites Understanding: Disease Overview

Ascites is the pathological accumulation of fluid in the peritoneal cavity, most commonly associated with liver cirrhosis but also linked to malignancies, heart failure, and infections like tuberculosis. It often presents with abdominal distension, discomfort, and weight gain. Underlying pathophysiology includes portal hypertension and hypoalbuminemia in cirrhosis, while malignant ascites arises from peritoneal carcinomatosis. Diagnostic evaluation typically involves imaging and paracentesis to determine cause and guide management, given its association with significant morbidity.

Ascites Epidemiology Perspective

The ascites epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the ascites epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for ascites and its trends. The ascites detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Ascites is the most common complication of cirrhosis, with a prevalence of approximately 10% among patients with cirrhosis and developing in nearly 60% of compensated cirrhosis cases within 10 years, significantly contributing to decompensation and poor prognosis.
• A recent meta-analysis of 99 studies reported the global pooled prevalence of spontaneous bacterial peritonitis (SBP), a major infection in ascitic patients, at 17.12%, with a global mortality rate of 30.61%, indicating its critical clinical impact.

Read more about this report - Request a Free Sample

Country-wise Ascites Epidemiology Segment

The ascites epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

In the United States, ascites represents a significant complication of cirrhosis, particularly among older adults. A 2022 cohort study reported that 10.7% of patients with cirrhosis developed ascites within five years, with 2.4% requiring paracentesis for symptomatic relief. This highlights both the prevalence and clinical burden of ascites in the aging cirrhotic population. Early recognition and management are essential to prevent further decompensation and associated morbidity. These findings underscore the importance of monitoring and intervention strategies for cirrhotic patients at risk of ascites.

Ascites: Treatment Overview

The management of the condition depends on the underlying cause. For instance, in cirrhosis-related ascites, sodium restriction and diuretics (spironolactone, furosemide) are first-line. Refractory cases may require large-volume paracentesis or transjugular intrahepatic portosystemic shunt (TIPS). Malignant ascites may be addressed with serial drainage, intraperitoneal therapies, or systemic cancer treatments. Antibiotic prophylaxis is considered in patients at risk of spontaneous bacterial peritonitis. Palliative measures focus on symptom relief and improving quality of life, especially in terminal disease stages.

Key Questions Answered

• What are the key findings of ascites epidemiology in the 8 major markets?
• What will be the total number of patients with ascites across the 8 major markets during the forecast period?
• What was the country-wise ascites epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of ascites patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of ascites during the forecast period of 2026-2035?
• What are the currently available treatments for ascites?
• What are the disease risks, signs, symptoms, and unmet needs of ascites?

Scope of the Ascites Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of ascites based on several factors.
• Ascites Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The ascites report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Ascites Market

Peritoneal Dialysis Market